Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype.
Ippolito JE, Hartig JP, Bejar K, Nakhoul H, Sehn JK, Weimholt C, Grimsley G, Nunez E, Trikalinos NA, Chatterjee D, Kim EH, Mehta AS, Angel PM, Troyer DA, Leach RJ, Corey E, Wu JD, Drake RR. Ippolito JE, et al. Among authors: wu jd. Mol Cancer Res. 2025 Jan 2;23(1):59-70. doi: 10.1158/1541-7786.MCR-24-0660. Mol Cancer Res. 2025. PMID: 39417716 Free PMC article.
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI.
Hartig JP, Bejar K, Young LEA, Grimsley G, Bethard JR, Troyer DA, Hernandez J, Wu JD, Ippolito JE, Ball LE, Gelfond JAL, Johnson-Pais TL, Mehta AS, Leach RJ, Angel PM, Drake RR. Hartig JP, et al. Among authors: wu jd. Cancer Res Commun. 2024 Nov 1;4(11):3036-3048. doi: 10.1158/2767-9764.CRC-24-0152. Cancer Res Commun. 2024. PMID: 39347566 Free PMC article.
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial.
Zhao ZR, Liu SL, Zhou T, Chen G, Long H, Su XD, Zhang X, Fu JH, Lin P, Zhang LJ, Rong TH, Wu JD, Li ZC, Su HL, Chen JY, Yang YP, Lin YB, Xi M, Yang H. Zhao ZR, et al. Among authors: wu jd. Lancet Respir Med. 2024 Dec;12(12):988-996. doi: 10.1016/S2213-2600(24)00215-7. Epub 2024 Sep 18. Lancet Respir Med. 2024. PMID: 39305910 Clinical Trial.
242 results